Coronavirus/COVID-19 Threatens a Decline in M&A Activity
Time 2 Minute Read

As coronavirus (COVID-19) continues to spread globally, precautions such as event postponement, travel cancellations and avoidance of crowds are having a significant economic impact, with many retailers being hit especially hard. After several years of solid market performance and economic growth, panic surrounding COVID-19 has resulted in volatility and significant drops in the stock market, creating less favorable economic conditions for M&A activity.

While many firms began 2020 feeling optimistic about another strong year for deal activity, the effects of COVID-19 have dampened those expectations, with data from Dealogic showing that global M&A activity is on track for its slowest two months in almost 15 years. Currently, some new deals are still being announced; however, ongoing effects from the COVID-19 outbreak may threaten existing negotiations or cause companies to abandon plans to engage in future transactions. Many sellers may choose to delay sale processes, but market conditions will also create unique opportunities for some buyers. Decreased valuations created by declining markets may allow for strategic acquisitions at discounted prices by companies and private equity firms that have sufficient cash on hand.

For companies that are currently either negotiating M&A transactions or in the process of closing pending transactions, there are several considerations created by the COVID-19 outbreak, including the potential delay of governmental and regulatory approvals and possible triggering of material adverse effect provisions of purchase documents or of force majeure provisions in material contracts of target companies. Ultimately, it remains to be seen whether these conditions are only temporary and economic recovery will happen as the spread of COVID-19 is controlled or whether these events could signal the start of a longer-term bear market or economic recession.

Additional resources on the legal implications of COVID-19 for businesses are available here.

You May Also Be Interested In

Time 3 Minute Read

On October 12, 2022, the UK Information Commissioner's Office (“ICO”) launched a public consultation on its draft guidance on employers’ obligations when monitoring at work (“Draft Guidance”). In addition, the ICO has published an impact scoping document, which outlines some of the context and potential impacts of the Draft Guidance (“Impact Scoping Document”).

Time 3 Minute Read

Over the last two years, courtesy of a once-a-century pandemic, government-mandated business closures, nationwide stay-at-home orders, and—unprecedented—disruptions to the global supply chain have illuminated, previously unknown, vulnerabilities across a whole host of industries. Would anyone have seriously questioned the viability of office space two years ago? Now, inflation, in keeping with the recent chaos, may be upending the viability of another tried-and-tested institution: the supply contract.

Time 2 Minute Read

The FTC, through the Department of Justice, has entered a settlement with two companies and the joint corporate President for falsely claiming that the LED lighting products and personal protective equipment (PPE) they sold were “Assembled in the USA,” “Buy American Act Compliant,” “Manufactured in the USA” and “100% Made in the USA,” despite having been imported from China. According to the FTC’s complaint, the defendants, Axis LED Group, LLC, ALG-Health LLC and Adam J. Harmon, went so far as to peel “Made in China” stickers off the products and replace them with Made in USA labels. The FTC had previously investigated and warned the companies, and received assurances that they would remove unqualified Made in USA claims from their marketing materials. The defendants subsequently were investigated by the National Institute for Occupational Safety & Health (NIOSH) over safety superiority claims for their KN95 masks.

Time 4 Minute Read

On June 13, 2022, the U.S. Department of Health and Human Services Office for Civil Rights (“OCR”) released guidance to help covered entities understand how they can use remote communication technologies for audio-only telehealth in compliance with the HIPAA Privacy and Security Rules (the “Guidance”). Specifically, the Guidance clarifies how audio-only telehealth can be conducted after OCR’s Notification of Enforcement Discretion for Telehealth (the “Telehealth Notification”), put in place during the COVID-19 pandemic, is no longer in effect.

Search

Subscribe Arrow

Recent Posts

Categories

Tags

Authors

Archives

Jump to Page